Human Stem Cell Bank at UMASS Medical School Makes Available First Seven Stem Cell Lines
The first seven stem cell lines grown and banked at the University of Massachusetts Medical School's Human Stem Cell Bank are ready for worldwide distribution to researchers working on discovering new treatments for diseases such as juvenile diabetes (also known as type 1 diabetes, type 2 diabetes, cancer and numerous other diseases.
“Stem cells are different from other cells because they have the ability to not only renew themselves for long periods, but with the right signals, become many different types of cells. Because of these unique properties, scientists are able to use stem cells to learn what makes individual cell types unique, how an organism develops from a single cell to an adult and how healthy cells replace damaged cells in adult organisms.” This is an important milestone for the Human Stem Cell Bank," said Joseph C. Laning, PhD, senior director of the Human Stem Cell Bank and Registry. "Our goal has always been to provide researchers with the highest quality stem cell lines so they know what they are getting and that the cells they get will perform as described. Having these stem cell lines tested, verified and available frees researchers from the expense and burden of manufacturing cell lines themselves, allowing them instead to focus on their research."
Six additional stem cell lines from Dr. Daley's lab have been banked and are scheduled to be made available for distribution later this year. The development of these stem cell lines could put an end to type 1 and type 2 diabetes as well as several types of cancer, Parkinson’s, Alzheimer’s and several other medical conditions. It will of course, take time but at least there is a light at the end of the tunnel now.